WeCann Academy
- Company typePrivate
- Founded2020
- HeadquartersBrasil, Brazil
- Headcount1–10
- GTM typeB2C
- OfferingServices
What WeCann Academy does
WeCann Academy (legally Wecann Endocannabinoid Global Academy Ltda, CNPJ 39.405.784/0001-73) is a Brazil-based medical education company founded in 2020 and headquartered in Florianópolis, operating with a 1–10 person team. It delivers an International Certification in Endocannabinoid Medicine to physicians, comprising more than 80 recorded classes, weekly live sessions with simultaneous Portuguese/English/Spanish translation, specialty-organized clinical case discussion forums, and a digital masterbook. The portfolio also includes the Treatise on Endocannabinoid Medicine (a textbook compiled from over 2,000 scientific articles), the annual WeCann Summit in Campinas, São Paulo (positioned as the world's largest Endocannabinoid Medicine congress), the peer-reviewed Medicinal Cannabis Evidence Map published in Frontiers in Pharmacology, and recurring content products (WeCann Talks, WeCann Rounds, blog/newsletter).
The commercial model combines a one-time material fee (R$ 2,700) with 12 monthly service installments for the certification program, plus separate revenue from treatise sales (digital and physical copies shipped free within Brazil) and Summit passport fees. Go-to-market is direct-to-physician via the wecann.academy website, supplemented by event-driven demand generation through the Summit, SEO/content marketing, email newsletter, and institutional support from medical societies and pharmaceutical sponsors. Cumulative scale signals include 4,000+ trained physicians, 40,000+ physicians reached through online events across 62 countries, 2,500+ Summit attendees, and a faculty of 30+ international experts from 15 countries.
The company is privately held with no disclosed external funding, parent entity, or institutional investors. Primary customer segments are practicing physicians across 60+ specialties, with secondary identified segments of veterinarians and dentists. Competitive positioning rests on being the most comprehensive and rigorous endocannabinoid medicine curriculum globally, addressing the systematic omission of the Endocannabinoid System from traditional medical education and serving physicians who treat chronic, refractory, and debilitating patients.
WeCann Academy firmographics
Firmographics- Name
- WeCann Academy
- Legal name
- Wecann Endocannabinoid Global Academy Ltda
- Website
- https://wecann.academy
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
WeCann Academy industry classification
Industry- Product category
- Medical Professional Education
- NAICS
- Professional and Management Development Training (611430)
- SIC
- Services-Educational Services (8200)
- akta.pro primary industry
- Healthcare & Clinical Professional Development (CME/CE) (EDAGANAJ)
- akta.pro secondary industry
- Pharmaceuticals & Biotechnology (EDABALAU)
Keywords
Where WeCann Academy is headquartered
LocationHeadquarters
- HQ city
- Brasil
- HQ country
- Brazil
- HQ region
- Latin America
Offices1 record
Markets served
WeCann Academy business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- International Certification Program: Primary revenue stream from medical certification program featuring 80+ recorded classes, weekly live meetings, clinical case discussions, digital textbook, and specialized content tracks. Billed as one-time material purchase (R$ 2,700) plus 12 monthly installments for service provision.
- Endocannabinoid Medicine Treatise: Sale of the digital and physical textbook 'Tratado de Medicina Endocanabinoide', compiled from over two thousand scientific articles. Physical copies shipped free throughout Brazil.
- WeCann Summit Events: Revenue from annual congress attendance including food included in passport price, held at major event venues in Brazil. Features pharmaceutical laboratories and sector companies as sponsors.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Multi-year contract | International Certification in Endocannabinoid Medicine |
| One time/ perpetual license | Pay-as-you-go | Endocannabinoid Medicine Treatise (Livro Digital) |
| One time/ perpetual license | Pay-as-you-go | WeCann Summit Passport |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels7 records
WeCann Academy product offering
Product offeringCore offering
WeCann Academy sells an International Certification in Endocannabinoid Medicine program for physicians, delivered through a proprietary LMS with 80+ recorded classes, weekly live expert meetings, specialty-organized clinical case discussion forums, and a digital masterbook. The portfolio also includes the Treatise on Endocannabinoid Medicine textbook, the annual WeCann Summit congress, and the peer-reviewed Medicinal Cannabis Evidence Map, all targeted at practicing physicians across 62 countries.
Product overview
WeCann Academy is an international medical education platform offering a comprehensive certification program in Endocannabinoid Medicine. The portfolio centers on the International Certification in Endocannabinoid Medicine (featuring 80+ recorded classes, weekly live meetings, and clinical case discussion forums), complemented by the Treatise on Endocannabinoid Medicine (a comprehensive textbook with 2,000+ scientific articles), the annual WeCann Summit (world's largest endocannabinoid medicine congress), and the Medicinal Cannabis Evidence Map. Additional offerings include the WeCann Blog/Newsletter for ongoing clinical updates and a Beginner's Guide for product selection. The platform serves physicians across 62 countries with content translated in Portuguese, English, and Spanish.
Differentiator
Problem solved
Functional benefit
Brands
- WeCann Summit: Annual international congress on Endocannabinoid Medicine and New Frontiers in Medicine, described as the world's largest medical congress in this field.
- WeCann Talks
- WeCann Rounds
- Masterbook Digital
Products and services
- International Certification in Endocannabinoid Medicine Comprehensive medical certification program for physicians featuring 80+ recorded classes, weekly live meetings with simultaneous translation in Portuguese, English, and Spanish, a specialty-organized clinical case discussion platform, curated content tracks across 12+ medical specialties, a digital masterbook textbook, and a faculty of 30+ international experts from 15 countries.
- Treatise on Endocannabinoid Medicine (Tratado de Medicina Endocanabinoide) A comprehensive textbook available in digital and physical formats, compiled from more than 2,000 scientific articles, recognized internationally as the most rigorous manual in endocannabinoid medicine. Covers clinical applications and prescriptive guidelines across medical specialties, with free shipping for physical copies throughout Brazil.
- WeCann Summit Annual international medical congress on Endocannabinoid Medicine and New Frontiers in Medicine, held in Campinas, São Paulo, Brazil. The world's largest endocannabinoid medicine congress, featuring 70+ speakers from four continents, 2,500+ physician attendees from 60+ specialties, pharmaceutical laboratory sponsors, and medical society institutional support. Passports include food and access to all conference content.
- Medicinal Cannabis Evidence Map (Mapa de Evidências da Cannabis Medicinal) High-impact scientific publication analyzing 194 rigorously studied clinical conditions demonstrating proven efficacy of medicinal cannabis across 20 clinical conditions. Provides technical and impartial reconciliation of available scientific evidence, peer-reviewed and published in the Frontiers in Pharmacology journal.
Quantifiable outcome
- 4,000+ physicians trained through certification programs
- +4 more outcomes
Companies that use WeCann Academy
Customer profileNamed customers5 records
Segments3 records
Ideal customer profiles2 records
WeCann Academy technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
WeCann Academy partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Frontiers in PharmacologyflagshipPeer-reviewed publication of the Medicinal Cannabis Evidence Map (Mapa de Evidências) in Frontiers in Pharmacology journal, establishing scientific credibility and academic recognition for WeCann's evidence-based approach to endocannabinoid medicine education.
Scale indicators9 records
Recent moves6 records
Expansion highlights5 records
WeCann Academy competitors and assessment
Company assessmentMarket position
Strengths4 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
WeCann Academy financial estimates
Financial estimateRevenue estimate
Valuation estimate
WeCann Academy leadership team
Management profileNumber of profiles
WeCann Academy funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
WeCann Academy M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about WeCann Academy
What does WeCann Academy do?
WeCann Academy sells an International Certification in Endocannabinoid Medicine program for physicians, delivered through a proprietary LMS with 80+ recorded classes, weekly live expert meetings, specialty-organized clinical case discussion forums, and a digital masterbook. The portfolio also includes the Treatise on Endocannabinoid Medicine textbook, the annual WeCann Summit congress, and the peer-reviewed Medicinal Cannabis Evidence Map, all targeted at practicing physicians across 62 countries.
Is WeCann Academy a public or private company?
WeCann Academy is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was WeCann Academy founded?
WeCann Academy was founded in 2020. It employs 1 to 10 people.
Where is WeCann Academy based?
WeCann Academy is headquartered in Brasil, Brazil, in the Latin America region.
How does WeCann Academy make money?
Three revenue lines are on record. International Certification Program is the primary driver. The others are endocannabinoid Medicine Treatise and weCann Summit Events.
Does WeCann Academy have an API?
No public API is recorded for WeCann Academy.
What industry is WeCann Academy in?
WeCann Academy's product category is Medical Professional Education. Its primary akta.pro industry code is EDAGANAJ, Healthcare & Clinical Professional Development (CME/CE), with a secondary code of EDABALAU, Pharmaceuticals & Biotechnology. Its NAICS code is 611430 and its SIC code is 8200.